CandleFocus

Crypto, humanity, and science: DeFi community comes together to fund Hankinson Lab rare disease research

Tech CEO Siqi Chen turned to social media to raise funds for research into a rare brain tumor affecting his daughter. He raised $75,000 of his $100,000 goal in a few hours, prompting the creation of a cryptocurrency called $MIRA to contribute to the fundraising effort. The coin's value reached $400,000, and Chen pledged to sell 10% of his supply to contribute to rare disease research. The CEO's commitment to transparency and integrity garnered support from the crypto community. His story highlights the rise of decentralized science (DeSci) within the cryptocurrency and biotech sectors. BIO Protocol, a decentralized biotech company, commented that science funding will be one of crypto's major use cases. BIO Protocol, supported by Binance Labs, aims to address funding gaps in areas such as rare diseases and longevity research. The organization has introduced intellectual property non-fungible tokens (IP-NFTs) to foster collaboration and innovation. Several BioDAOs under BIO Protocol's umbrella have achieved significant milestones.

Related News